Internal Medicine, Gastroenterology · Houston, TX
NPI
1992029979
Since 2010
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1504 Taub Loop
Houston, TX, 77030
Phone (713) 873-8890
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
112,305 services
Medicare patients, 2024
294
Average age 71
Drug cost, 2024
$2.3M
408 prescriptions
Company payments, 2025
$30K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richa Shukla was code J3262 (injection, tocilizumab, 1 mg), 17,520 times for 11 patients. In total Richa Shukla billed 112,305 services in 78 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 17,520 | 11 | $4.69 | $82K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 5,250 | 11 | $8.61 | $45K |
| J0897 Injection, denosumab, 1 mg | Office | 4,320 | 55 | $20.63 | $89K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,270 | 16 | $24.87 | $81K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,715 | 28 | $0.23 | $622 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 435 | 136 | $0.51 | $223 |
| 96413 Chemotherapy Administration | Office | 217 | 81 | $104.76 | $23K |
| 96401 Chemotherapy Administration | Office | 170 | 77 | $58.07 | $9,871 |
| 96365 Intravenous Infusion, Hydration | Office | 149 | 58 | $49.31 | $7,346 |
| 96415 Chemotherapy Administration | Office | 130 | 36 | $22.52 | $2,928 |
| 96375 Injection Administration | Office | 125 | 32 | $12.47 | $1,558 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 125 | 25 | $4.55 | $569 |
| 96366 Intravenous Infusion, Hydration | Office | 106 | 17 | $16.50 | $1,749 |
| J7060 5% dextrose/water (500 ml = 1 unit) | Office | 60 | 16 | $1.41 | $84.38 |
| 36415 Venipuncture Blood Collection | Office | 54 | 31 | $8.65 | $467 |
By year: 2022 $1.5M for 44,314 services; 2023 $1.7M for 66,272 services; 2024 $1.7M for 112,305 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 54 | 31 | $8.65 | $467 |
Medicare prescription drug claims, 2024
In 2024, the drug Richa Shukla prescribed most often to Medicare patients was Omeprazole, with 49 prescriptions and refills. In total Richa Shukla wrote 408 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 49 | 93 | 17 | $855 |
| Stelara Ustekinumab | 47 | 76 | Under 11 | $1.3M |
| Skyrizi On-Body Risankizumab-Rzaa | 26 | 47 | Under 11 | $556K |
| Rinvoq Upadacitinib | 21 | 29 | Under 11 | $196K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 17 | 17 | 17 | $980 |
| Sulfasalazine Generic | 17 | 33 | Under 11 | $449 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 16 | 16 | Under 11 | $272 |
| Mesalamine Generic | 16 | 36 | Under 11 | $12K |
| Azathioprine Generic | 15 | 25 | Under 11 | $1,004 |
| Dicyclomine Hcl Generic | 14 | 24 | Under 11 | $437 |
| Humira Pen Adalimumab | 13 | 13 | Under 11 | $195 |
| Remicade Infliximab | 12 | 12 | Under 11 | $97K |
| Amitriptyline Hcl Generic | 12 | 14 | Under 11 | $150 |
| Proctofoam-Hc Hydrocortisone/Pramoxine | 12 | 12 | Under 11 | $4,580 |
Brand drugs: 179 claims; generic drugs: 229 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richa Shukla $30K ($30K in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $16K |
| Lilly USA, LLC LLY | 10 | $13K |
| Janssen Biotech, Inc. JNJ | 7 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $114 |
| Intercept Pharmaceuticals, Inc. | 5 | $95.68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $88.4 |
| ERBE USA Inc | 1 | $86.19 |
| Madrigal Pharmaceuticals MDGL | 1 | $22.35 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $18.96 |
| Pfizer Inc. PFE | 1 | $18.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.